BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17637539)

  • 1. [A phase II study of weekly paclitaxel for advanced or recurrent breast cancer].
    Wada Y; Otoshi M; Jitsuko A; Nishikawa H; Takahara S; Tsubono M; Imai S
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1041-5. PubMed ID: 17637539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safety of weekly taxol (TXL) for advanced recurrent breast cancer evaluated in a multi-center cooperative clinical trial].
    Nishi T; Yamanaka E; Yamasaki M; Tanaka H; Takeda C; Ikeda N; Hoashi T; Higaki J; Matsunami T; Nakano K; Kogire M; Furukawa J; Inui N; Yamauchi E; Takagaki K; Ogino N; Nomura T; Yamada S; Fujimoto M; Uenishi M; Yayoi E;
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):897-901. PubMed ID: 15222108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of biweekly paclitaxel therapy in advanced or recurrent breast cancer].
    Kuroi K; Tanaka C; Bando H; Saji S; Hayashi K; Toi M
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):55-60. PubMed ID: 11816478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Weekly administration regimen of paclitaxel (PTX) in patient with inoperable or recurrent gastric cancer].
    Kii T; Takiuchi H; Gotoh M; Kawabe S; Ohta S; Tanaka T; Kuwakado S; Nishitani H; Katsu K
    Gan To Kagaku Ryoho; 2006 May; 33(5):621-4. PubMed ID: 16685160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Weekly administration of low-dose paclitaxel for advanced or metastatic breast cancer].
    Uno Y; Hirano M; Murakami N; Kikuchi T; Nozawa H; Okuda T; Oya J; Kikkawa H
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):227-32. PubMed ID: 11865628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of weekly administration of paclitaxel for advanced or recurrent gastric cancer].
    Egawa T; Kubota T; Nagashima A; Doi M; Kitano M; Hayashi S; Yoshii H; Saikawa Y; Kitajima M
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):877-81. PubMed ID: 15222104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan.
    Horiguchi J; Rai Y; Tamura K; Taki T; Hisamatsu K; Ito Y; Seriu T; Tajima T
    Anticancer Res; 2009 Feb; 29(2):625-30. PubMed ID: 19331212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Weekly paclitaxel therapy for metastatic breast cancer].
    Kokufu I; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):221-6. PubMed ID: 11865627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and therapeutic efficacy of weekly 1-h low-dose paclitaxel infusion for relapsed breast cancer.
    Kim R; Osaki A; Toge T
    Oncol Rep; 2003; 10(1):145-50. PubMed ID: 12469161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Weekly administration of paclitaxel and pirarubicine for recurrent breast cancer].
    Shimizu T; Iwasa T; Koike S; Nakamura T; Kanai T; Komatsu D
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):105-9. PubMed ID: 12557713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Feasibility study of weekly paclitaxel as second-line chemotherapy against 5-FU-refractory gastric carcinoma].
    Ito S; Kodera Y; Mochizuki Y; Yamamura Y
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1427-30. PubMed ID: 16227742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Weekly paclitaxel therapy for locoregional lymph node recurrence of estrogen-receptor-negative breast cancer].
    Nishimura H; Hamanaka K; Sakai H; Ohno Y; Miyagawa Y; Seki H; Munakata Y
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):627-30. PubMed ID: 15114714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical efficacy and safety of weekly paclitaxel therapy as second-line chemotherapy for patients with advanced and recurrent gastric cancer who were previously treated with TS-1 therapy].
    Hatori S; Kunisaki C; Ono H; Sato T; Otsuka Y; Yamada R; Ohshima T; Rino Y; Imada T
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1257-60. PubMed ID: 16969021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Weekly administration of paclitaxel for advanced or metastatic breast cancer--short-course premedications for outpatients].
    Kimura M; Koida T; Yanagita Y
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1703-8. PubMed ID: 11057321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
    Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T;
    Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of weekly paclitaxel administration for patients with relapsed cervical cancer after heavy medication.
    Terauchi F; Nagashima T; Kobayashi Y; Yamamoto Y; Moritake T; Seiki T; Ogura H
    Gan To Kagaku Ryoho; 2005 May; 32(5):641-4. PubMed ID: 15918564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of 3-h infusion of paclitaxel in patients with adenocarcinoma of endometrium: Japanese Multicenter Study Group.
    Hirai Y; Hasumi K; Onose R; Kuramoto H; Kuzuya K; Hatae M; Ochiai K; Nozawa S; Noda K
    Gynecol Oncol; 2004 Aug; 94(2):471-6. PubMed ID: 15297190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Weekly paclitaxel administration in the adjuvant therapy of primary breast cancer].
    Takahashi H; Takahashi M; Taguchi K; Sasaki F; Todo S
    Gan To Kagaku Ryoho; 2003 May; 30(5):653-9. PubMed ID: 12795097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
    Penel N; Bui BN; Bay JO; Cupissol D; Ray-Coquard I; Piperno-Neumann S; Kerbrat P; Fournier C; Taieb S; Jimenez M; Isambert N; Peyrade F; Chevreau C; Bompas E; Brain EG; Blay JY
    J Clin Oncol; 2008 Nov; 26(32):5269-74. PubMed ID: 18809609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of weekly paclitaxel administration for metastatic breast cancer based on time to progression (TTP) and survival].
    Emoto T; Yoshikawa K; Yoshioka Y; Nezu R; Fujikawa M; Fujii M; Maeda S; Naka Y; Komaki T
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):817-22. PubMed ID: 12852349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.